Foros de Conocimiento
medtronic PRODUCTOS
boston_scientific PRODUCTOS
TERUMO PRODUCTOS
Biotronik PRODUCTOS
Sirtex PRODUCTOS
Striker Neurovascular PRODUCTOS
BIOSENSORS PRODUCTOS

ESTUDIOS


01 enero 2016

JACC: CARDIOVASCULAR INTERVENTIONS. Effect of Chronic Kidney Disease in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents

Usman Baber, Gennaro Giustino, Samantha Sartori, Melissa Aquino, Giulio G. Stefanini, P. Gabriel Steg, Stephan Windecker, Martin B. Leon, William Wijns, Patrick W. Serruys, Marco Valgimigli, Gregg W. Stone, George D. Dangas, Marie-Claude Morice, Edoardo Camenzind, Giora Weisz, Pieter C. Smits, David Kandzari, Clemens Von Birgelen, Ioannis Mastoris, Soren Galatius, Raban V. Jeger, Takeshi Kimura, Ghada W. Mikhail, Dipti Itchhaporia, Laxmi Mehta, Rebecca Ortega, Hyo-Soo Kim, Adnan Kastrati, Alaide Chieffo and Roxana Mehran

Objectives: This study sought to evaluate: 1) the effect of impaired renal function on long-term clinical outcomes in women undergoing percutaneous coronary intervention (PCI) with drug-eluting stent (DES); and 2) the safety and efficacy of new-generation compared with early-generation DES in women with chronic kidney disease (CKD).

01 enero 2016

JACC: CARDIOVASCULAR INTERVENTIONS. A Randomized Comparison of Reservoir-Based Polymer-Free Amphilimus-Eluting Stents Versus Everolimus-Eluting Stents With Durable Polymer in Patients With Diabetes Mellitus

Rafael Romaguera, Joan A. Gómez-Hospital, Josep Gomez-Lara, Salvatore Brugaletta, Eduardo Pinar, Pilar Jiménez-Quevedo, Montserrat Gracida, Gerard Roura, Jose L. Ferreiro, Luis Teruel, Eduard Montanya, Antonio Fernandez-Ortiz, Fernando Alfonso, Marco Valgimigli, Manel Sabate and Angel Cequier

Objectives: The aim of this study was to compare the efficacy of amphilimus-eluting stents (AES) with that of everolimus-eluting stents (EES) in patients with diabetes mellitus (DM).

01 enero 2016

JACC: CARDIOVASCULAR INTERVENTIONS. Polymer-Free Biolimus A9-Coated Stents in the Treatment of De Novo Coronary Lesions: 4- and 12-Month Angiographic Follow-Up and Final 5-Year Clinical Outcomes of the Prospective, Multicenter BioFreedom FIM Clinical Trial

Ricardo A. Costa, Alexandre Abizaid, Roxana Mehran, Joachim Schofer, Gerhard C. Schuler, Karl E. Hauptmann, Marco A. Magalhães, Helen Parise, Eberhard Grube and BioFreedom FIM Clinical Trial Investigators

Objectives: The purpose of this study was to evaluate the efficacy and long-term outcomes of a novel polymer/carrier-free drug-coated stent (DCS) in patients with de novo coronary lesions.

01 enero 2016

JACC: CARDIOVASCULAR INTERVENTIONS. Prospective Multicenter Evaluation of the Direct Flow Medical Transcatheter Aortic Valve System

Thierry Lefèvre, Antonio Colombo, Didier Tchétché, Azeem Latib, Silvio Klugmann, Jean Fajadet, Federico De Marco, Francesco Maisano, Giuseppe Bruschi, Klaudija Bijuklic, Stefano Nava, Neil Weissman, Reginald Low, Martyn Thomas, Christopher Young, Simon Redwood, Michael Mullen, John Yap, Eberhard Grube, Georg Nickenig, Jan-Malte Sinning, Karl Eugen Hauptmann, Ivar Friedrich, Michael Lauterbach, Michael Schmoeckel, Charles Davidson and Joachim Schofer

Objectives: The aim of this study was to assess the 1-year outcome after transcatheter aortic valve replacement (TAVR) of the Direct Flow Medical (DFM) valve in patients with severe symptomatic aortic stenosis who were contraindicated or high risk for surgery.

01 enero 2016

JACC: CARDIOVASCULAR INTERVENTIONS. Prevention of Contrast-Induced Nephropathy by Central Venous Pressure–Guided Fluid Administration in Chronic Kidney Disease and Congestive Heart Failure Patients

Geng Qian, Zhenhong Fu, Jun Guo, Feng Cao and Yundai Chen

Objectives: This study aimed to explore the hemodynamic index–guided hydration method for patients with congestive heart failure (CHF) and chronic kidney disease (CKD) to reduce the risk of contrast-induced nephropathy (CIN) and at the same time to avoid the acute heart failure.

01 enero 2016

JACC: CARDIOVASCULAR INTERVENTIONS. Thrombus Aspiration in Patients With ST-Segment Elevation Myocardial Infarction Presenting Late After Symptom Onset

Steffen Desch, Thomas Stiermaier, Suzanne de Waha, Philipp Lurz, Matthias Gutberlet, Marcus Sandri, Norman Mangner, Enno Boudriot, Michael Woinke, Sandra Erbs, Gerhard Schuler, Georg Fuernau, Ingo Eitel and Holger Thiele

Objectives: The aim of this study was to examine whether manual thrombus aspiration reduces microvascular obstruction assessed by cardiac magnetic resonance imaging in patients with ST-segment elevation myocardial infarction (STEMI) presenting late after symptom onset.

01 enero 2016

JACC: CARDIOVASCULAR INTERVENTIONS. Outcomes From Selective Use of Thrombectomy in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction

Alex Sirker, Mamas Mamas, Chun Shing Kwok, Evangelos Kontopantelis, Peter Ludman, David Hildick-Smith and British Cardiovascular Intervention Society (BCIS)

Objectives: This study used a large national cohort to examine patterns of thrombectomy use in ST-segment elevation myocardial infarction (STEMI) and the relationship to mortality.

01 enero 2016

JACC: CARDIOVASCULAR INTERVENTIONS. Benefits and Risks of Extended Dual Antiplatelet Therapy After Everolimus-Eluting Stents

James B. Hermiller, Mitchell W. Krucoff, Dean J. Kereiakes, Stephan Windecker, P. Gabriel Steg, Robert W. Yeh, David J. Cohen, Donald E. Cutlip, Joseph M. Massaro, Wen-Hua Hsieh, Laura Mauri and DAPT Study Investigators

Objectives: The purpose of this study was to characterize outcomes for everolimus-eluting stent (EES)–treated subjects according to treatment with continued thienopyridine plus aspirin versus aspirin alone 12 to 30 months after stenting.

01 enero 2016

JACC: CARDIOVASCULAR INTERVENTIONS. Effects of Mechanical Ventilation on Heart Geometry and Mitral Valve Leaflet Coaptation During Percutaneous Edge-to-Edge Mitral Valve Repair

Johannes Patzelt, Yingying Zhang, Peter Seizer, Harry Magunia, Andreas Henning, Veronika Riemlova, Tara A.E. Patzelt, Marc Hansen, Michael Haap, Reimer Riessen, Henning Lausberg, Tobias Walker, Joerg Reutershan, Christian Schlensak, Christian Grasshoff, Dan I. Simon, Peter Rosenberger, Juergen Schreieck, Meinrad Gawaz and Harald F. Langer

Objectives: This study sought to evaluate a ventilation maneuver to facilitate percutaneous edge-to-edge mitral valve repair (PMVR) and its effects on heart geometry.

01 enero 2016

JACC: CARDIOVASCULAR INTERVENTIONS. Cerebral Protection During MitraClip Implantation

Christian Frerker, Michael Schlüter, Oscar D. Sanchez, Sebastian Reith, Maria E. Romero, Elena Ladich, Jörg Schröder, Tobias Schmidt, Felix Kreidel, Michael Joner, Renu Virmani and Karl-Heinz Kuck

Objectives: This study sought to assess the feasibility and safety of using a filter-based cerebral protection system (CPS) during MitraClip implantation and to report on the histopathologic analysis of the captured debris.

01 febrero 2016

JACC: CARDIOVASCULAR INTERVENTIONS. Long-Term Outcome of Incomplete Revascularization After Percutaneous Coronary Intervention in SCAAR (Swedish Coronary Angiography and Angioplasty Registry)

Kristina Hambraeus, Karin Jensevik, Bo Lagerqvist, Bertil Lindahl, Roland Carlsson, Ramin Farzaneh-Far, Thomas Kellerth, Elmir Omerovic, Gregg Stone, Christoph Varenhorst and Stefan James

Objectives: The aim of this study was to describe current practice regarding completeness of revascularization in patients with multivessel disease undergoing percutaneous coronary intervention (PCI) and to investigate the association of incomplete revascularization (IR) with death, repeat revascularization, and myocardial infarction (MI) in a large nationwide registry.

01 febrero 2016

JACC: CARDIOVASCULAR INTERVENTIONS. Beneficial Effects of a Novel Bioabsorbable Polymer Coating on Enhanced Coronary Vasoconstricting Responses After Drug-Eluting Stent Implantation in Pigs in Vivo

Kensuke Nishimiya, Yasuharu Matsumoto, Hironori Uzuka, Tsuyoshi Ogata, Michinori Hirano, Tomohiko Shindo, Yuhi Hasebe, Ryuji Tsuburaya, Takashi Shiroto, Jun Takahashi, Kenta Ito and Hiroaki Shimokawa

Objectives: The aim of this study was to examine which component of drug-eluting stents (DES) plays a major role in enhanced coronary vasoconstricting responses after DES implantation in pigs.

01 febrero 2016

JACC: CARDIOVASCULAR INTERVENTIONS. Randomized Comparison of Different Thienopyridine Loading Strategies in Patients Undergoing Elective Coronary Intervention

Willibald Hochholzer, Michael Amann, Alexander Titov, Iris Younas, Nikolaus Löffelhardt, Florian Riede, Clemens Potocnik, Christian Stratz, Dieter Hauschke, Dietmar Trenk, Franz-Josef Neumann and Christian M. Valina

Objectives: This randomized trial investigated to what extent loading with prasugrel can provide a more rapid peri-interventional antiplatelet effect than clopidogrel 600 mg.

Utilizamos cookies propias para el correcto funcionamiento del sitio web y mejorar nuestros servicios. Pulse el botón Aceptar todas para aceptar su uso. Puede cambiar la configuración u obtener más información en nuestra Política de cookies o pulsando Modificar configuración.